Molecular pathogenesis of spinal and bulbar muscular atrophy

被引:15
|
作者
Merry, DE [1 ]
机构
[1] Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA
关键词
androgen receptor; polyglutamine; Kennedy's disease; protein aggregation;
D O I
10.1016/S0361-9230(01)00594-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Studies of the molecular pathogenesis of spinal and bulbar muscular atrophy, as well as of the other polyglutamine repeat diseases, has led to an understanding of the role of protein accumulation in disease pathogenesis. Aggregation of the expanded repeat androgen receptor (AR), rather than playing a pathogenic role, likely reflects the insoluble nature of the misfolded AR. Proteolytic processing of the expanded AR at various stages of its metabolism may contribute to cellular toxicity through the enhancement of AR insolubility, and potentially through the disruption of normal proteolytic degradation processes. The finding that molecular chaperones not only promote solubility, but also enhance the degradation of expanded polyglutamines as well, make them promising targets for therapeutic development. Understanding the role of ligand binding in expanded AR metabolism may provide additional avenues of therapeutic manipulation as well. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:203 / 207
页数:5
相关论文
共 50 条
  • [1] Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy
    Adachi, H.
    Waza, M.
    Katsuno, M.
    Tanaka, F.
    Doyu, M.
    Sobue, G.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2007, 33 (02) : 135 - 151
  • [2] Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)
    Katsuno, Masahisa
    Tanaka, Fumiaki
    Adachi, Hiroaki
    Banno, Haruhiko
    Suzuki, Keisuke
    Watanabe, Hirohisa
    Sobue, Gen
    PROGRESS IN NEUROBIOLOGY, 2012, 99 (03) : 246 - 256
  • [3] Spinal and bulbar muscular atrophy: pathogenesis and clinical management
    Grunseich, C.
    Rinaldi, C.
    Fischbeck, K. H.
    ORAL DISEASES, 2014, 20 (01) : 6 - 9
  • [4] Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA)
    Suzuki, Keisuke
    Kastuno, Masahisa
    Banno, Haruhiko
    Sobue, Gen
    NEUROPATHOLOGY, 2009, 29 (04) : 509 - 516
  • [5] The role of ubiquitination in spinal and bulbar muscular atrophy
    Sengupta, Medha
    Pluciennik, Anna
    Merry, Diane E.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [6] Pathogenesis, animal models and therapeutics in Spinal and bulbar muscular atrophy (SBMA)
    Katsuno, Masahisa
    Adachi, Hiroaki
    Waza, Masahiro
    Banno, Haruhiko
    Suzuki, Keisuke
    Tanaka, Fumiaki
    Doyu, Manabu
    Sobue, Gen
    EXPERIMENTAL NEUROLOGY, 2006, 200 (01) : 8 - 18
  • [7] Molecular pathogenesis of spinal bulbar muscular atrophy (Kennedy's disease) and avenues for treatment
    Grunseich, Christopher
    Fischbeck, Kenneth H.
    CURRENT OPINION IN NEUROLOGY, 2020, 33 (05) : 629 - 634
  • [8] Spinal and Bulbar Muscular Atrophy Overview
    Fischbeck, Kenneth H.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 58 (03) : 317 - 320
  • [9] Spinal and Bulbar Muscular Atrophy Overview
    Kenneth H. Fischbeck
    Journal of Molecular Neuroscience, 2016, 58 : 317 - 320
  • [10] Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives
    Masahisa Katsuno
    Hiroaki Adachi
    Fumiaki Tanaka
    Gen Sobue
    Journal of Molecular Medicine, 2004, 82 : 298 - 307